Navigation Links
Pharmaceutical Institute Launches New E-Course Focused on Health Policy
Date:6/17/2009

efforts, this module provides an overview of the existing health insurance landscape in the US. The roles played by both commercial health plans and the major government insurance programs are explored.
  • Health Reform Options -- For the first time in decades, major health insurance reform is at the top of the Capitol Hill agenda. This module clarifies the confusing array of reform options that are currently under consideration and explains the perspectives of advocates and opponents. Possible implications of change for the pharmaceutical and biotechnology sector are explored.
  • Hot Topics -- Health reform isn't the only front-burner health policy issue on Capitol Hill today. This module explores recent or proposed "movement" on five other pressing issues related to healthcare quality and cost, including Medicare Part D non-interference clause, comparative effectiveness research, drug reimportation, health information technology, and follow-on biologics. The discussion spotlights concerns that these issues have aroused in the pharmaceutical and biotechnology industry.

    • For more information on the Introduction to Health Policy e-course, please visit

    http://www.pharmainstitute.com/training-solutions/managed-markets/health-policy/index.cfm

    For more information on the Managed Markets Excellence(TM) e-course series, please visit

    http://www.pharmainstitute.com/training-solutions/managed-markets/i
    '/>"/>

    SOURCE Pharmaceutical Institute
    Copyright©2009 PR Newswire.
    All rights reserved

    2

    GOOD

    Page: 1 2 3

    Related biology technology :

    1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
    2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
    3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
    4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
    6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
    7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
    8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
    9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
    10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
    11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/20/2013)... 20, 2013 Interventional cardiologist Tony Farah, ... Hospital (AGH) Cardiovascular Institute have helped pioneer many ... disease (CAD) over the past three decades, from ... angioplasty and coronary artery stent implantation. , Today, AGH ... a prominent role in the study of a novel, ...
    (Date:5/20/2013)... France (PRWEB) May 20, 2013 On ... this time – in Paris - the beautiful city ... congress chairperson, "Personalized Medicine is revolutionizing the medical world. ... clinical knowledge is the hallmark of this transformation. Much ... care derived from the epidemiologic studies of large cohorts ...
    (Date:5/20/2013)... CA (PRWEB) May 20, 2013 The ... announced the appointment of Lisa Baird as Executive Director. ... July 8, 2013. The WMIS vision is ... applications to understand and effectively treat diseases in the ... Society (WMIS) was established in 2011 by integrating the ...
    (Date:5/17/2013)... 17, 2013 Topricin Pain Relief ... has been listed among nationally recommended over-the-counter (OTC) ... conducted by "U.S. News" Health in collaboration with ... “No. 1 Pharmacists Recommended designation” in the ... OTC brands, and is the only homeopathic formula ...
    Breaking Biology Technology:Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris 2WMIS Appoints Lisa Baird as Next Executive Director 2Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products 2
    ... DNDN ) today announced that management will present at the ... Merrill Lynch 2009 Health Care Conference, The New York ... 9:20 a.m. ET, Deutsche Bank Securities 34th Annual Healthcare ... 2009, 4:35 p.m. ET, Leerink Swann ...
    ... Arpida Ltd. (SIX:,ARPN) will today discuss potential strategic scenarios ... starts at 10am CET in Reinach,Switzerland. , ... iclaprim, Arpida has,initiated a thorough analysis with the aim ... by international experts in this field. , ...
    ... May 7 Cyprotex today,(7th May 2009) launches Cloe(R) ... discovery services. The initial offering via Cloe(R) Gateway is ... PK, which,predicts whole body pharmacokinetics from simple in vitro ... on the launch, Dr Anthony D. Baxter, Cyprotex,s Chief,Executive ...
    Cached Biology Technology:Arpida to Discuss Strategy With Shareholders 2Cyprotex Launches Cloe(R) Gateway, its Secure web Portal for Access to Cyprotex Services Including an Enhanced Version of Cloe(R) PK. 2
    (Date:5/17/2013)... Cargo in Efficient and Sustainable Global Logistics Operations) is ... in the efficiency of intermodal loading systems and the ... comprises 29 European organisations with experience in the logistics ... budget totalling 17,000,000 and a duration of three and ... and develop the semantic components and ontologies shared by ...
    (Date:5/16/2013)... FASEB MARC (Maximizing Access to Research Careers) Program ... Endocrine Society (ENDO) 95th Annual Meeting in San ... are meant to promote the entry of students, ... mainstream of the basic science community and to ... ENDO 2013 Annual Meeting. , Awards are given ...
    (Date:5/16/2013)... nanoparticles developed at MIT may someday eliminate the ... constantly monitor their blood-sugar levels and inject themselves ... sense glucose levels in the body and respond ... replacing the function of pancreatic islet cells, which ... Ultimately, this type of system could ensure that ...
    Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2Nanotechnology could help fight diabetes 2Nanotechnology could help fight diabetes 3
    ... An international team of researchers, including Monash University biochemists, ... of one of the key tenets of Darwin,s theory ... said the breakthrough, funded by the Australian Research Council ... , provides a blueprint for a general understanding of ...
    ... A network of proteins underlying the plasma membrane keeps epithelial ... the mouse lens, say Nowak et al. The study will ... Journal of Cell Biology (online September 14). Spectrin, ... shapes the plasma membrane of red blood cells. A similar ...
    ... MD, PhD, of the Gladstone Institute of Cardiovascular Disease (GICD) ... Medical Research Award for his discovery of a method of ... who is the L.K.Whittier Investigator in Stem Cell Biology at ... the youngest recipients of the award, which is seen as ...
    Cached Biology News:Evolution still scientifically stable 2Gladstone's Shinya Yamanaka wins Lasker Award 2
    ... Phosphatase-2A (PPase-2A) is a serine/threonine phosphatase isolated ... isolated as the heterodimer of 60kDa (A) ... ability to dephosphorylate the a-subunit of phosphorylase ... has broad substrate specificity and may play ...
    ... a high performance spectral scanning multimode ... With the advanced SkanIt Software it ... drug discovery assay development. Varioskan provides ... time-resolved fluorescence and photometric assays and ...
    ... a wide variety of solvent vapors that can contaminate ... (GCF400) allows for the collection of liquid into a ... minimizes waiting period., Ultra low -104 o ... , Digital Display of temperature ...
    Immulon 2HB, Flat Bottom, 50/Bx; high binding irradiated surface to provide increased binding affinity for hydrophilic proteins and complexes....
    Biology Products: